Rakovina Therapeutics Inc.
RKV.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -149.51% | -94.30% | -53.06% | -29.37% | -11.49% |
| Total Depreciation and Amortization | -3.15% | -3.31% | -1.21% | -0.58% | -0.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 65.53% | 95.76% | 18.97% | 42.37% | 28.01% |
| Change in Net Operating Assets | -211.42% | -301.82% | -2,581.65% | 182.78% | 436.55% |
| Cash from Operations | -391.18% | -154.78% | -102.32% | -26.39% | 30.82% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 200.00% |
| Issuance of Common Stock | 304.59% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -82.43% | -67.02% | -67.02% | 28.37% | -- |
| Cash from Financing | 373.16% | 227.15% | 227.15% | 34.18% | 15.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 209.62% | 83.54% | 282.61% | -5.73% | 122.74% |